Gt Biopharma, Inc. reported raising $5.61 Million in an initial SEC Form D filing, from an offering of $4.54 Million
Amount Raised
$5.61 Million
Round Type
Venture
San FranciscoBiotechnologyQuick answer
GT Biopharma raised $5.61 Million in a funding round, dated September 14, 2017. GT Biopharma is based in San Francisco, California, United States.
- How much did GT Biopharma raise?
- GT Biopharma raised $5.61 Million in a funding round on September 14, 2017.
- What does GT Biopharma do?
- GT Biopharma is a biotechnology company developing novel immuno-oncology biopharmaceutical drugs using its proprietary NK cell engager (TriKE) platform technology.
- Where is GT Biopharma based and how big is it?
- GT Biopharma is based in San Francisco, California, United States. Fundz records about 8 employees.
- Who are the decision-makers at GT Biopharma?
- Fundz holds 1 contact at GT Biopharma. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as GT Biopharma that raised within 45 days of this round, from Fundz verified event records.
- SILK TECHNOLOGIES, LTD. raised $5M on October 26, 2017.
- EmboMedics, Inc. raised $741K (Seed) on October 25, 2017.
- Helixbind, Inc. raised $2.9M (Seed) on October 24, 2017.
- GeneCapture raised $55K (Pre-Seed) on October 23, 2017.
- Portal Instruments, Inc. raised $6M on October 20, 2017.
- Kineta, Inc. raised an undisclosed amount on October 20, 2017.
Who to call at GT Biopharma, and when
A new round usually means GT Biopharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day GT Biopharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at GT Biopharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at GT Biopharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment GT Biopharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
GT Biopharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.